Logo image of 1CYTH.MI

LUMEN TECHNOLOGIES INC (1CYTH.MI) Stock Earnings & Estimates

Europe - Euronext Milan - BIT:1CYTH - US5502411037 - Common Stock

9.137 EUR
-0.55 (-5.64%)
Last: 11/7/2025, 7:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
1CYTH.MI revenue by date.1CYTH.MI revenue by date.
17.478B
-11.22%
14.557B
-16.71%
13.108B
-9.95%
12.617B
-3.75%
11.792B
-6.54%
11.593B
-1.69%
10.959B
-5.47%
10.887B
-0.66%
10.933B
0.42%
10.306B
-5.73%
9.635B
-6.51%
EBITDA
YoY % growth
1CYTH.MI ebitda by date.1CYTH.MI ebitda by date.
6.532B
-21.34%
4.215B
-35.47%
3.433B
-18.55%
3.39B
-1.25%
3.524B
3.95%
3.647B
3.49%
3.416B
-6.33%
3.457B
1.20%
3.496B
1.13%
3.545B
1.40%
3.413B
-3.72%
EBIT
YoY % growth
1CYTH.MI ebit by date.1CYTH.MI ebit by date.
3.293B
-23.15%
1.23B
-62.65%
477M
-61.22%
-409.523M
-185.85%
410.5M
200.24%
596.85M
45.40%
820.08M
37.40%
905.76M
10.45%
1.055B
16.48%
1.202B
13.93%
1.255B
4.41%
Operating Margin
1CYTH.MI operating margin by date.1CYTH.MI operating margin by date.
18.84%8.45%3.64%-3.25%3.48%5.15%7.48%8.32%9.65%11.66%13.03%
EPS
YoY % growth
1CYTH.MI eps by date.1CYTH.MI eps by date.
1.55
-18.85%
0.19
-87.74%
-0.21
-210.53%
-0.67
-220.63%
-0.57
14.81%
-0.30
47.54%
0.02
106.78%
0.06
200.00%
0.08
33.33%
0.11
37.50%
N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.21
-329.16%
-0.19
-46.46%
-0.15
-401.50%
-0.20
-2.00%
-0.15
25.82%
Revenue
Q2Q % growth
3.093B
-7.09%
3.04B
-4.46%
3.017B
-2.43%
2.948B
-4.50%
2.986B
-3.46%
EBITDA
Q2Q % growth
812.21M
-73.88%
868.88M
5.96%
887.89M
-37.74%
863.02M
-55.95%
923.58M
13.71%
EBIT
Q2Q % growth
33.578M
-78.20%
82.589M
-22.81%
118.09M
372.36%
-68.34M
41.09%

-100.00%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.20
-53.85%
-0.270.0726.21%
Q2 2025
Q2Q % growth
-0.03
76.92%
-0.270.2488.84%
Q1 2025
Q2Q % growth
-0.13
-225.00%
-0.270.1452.11%
Q4 2024
Q2Q % growth
0.09
12.50%
-0.050.14272.03%
Q3 2024
Q2Q % growth
-0.13
-44.44%
-0.09-0.04-45.54%
Q2 2024
Q2Q % growth
-0.13
-230.00%
-0.06-0.07-118.13%
Q1 2024
Q2Q % growth
-0.04
-140.00%
0.00-0.04-1,348.91%
Q4 2023
Q2Q % growth
0.08
-81.40%
-0.010.09813.01%
Q3 2023
Q2Q % growth
-0.09
-164.29%
0.06-0.15-239.22%
Q2 2023
Q2Q % growth
0.10
-71.43%
-0.360.46127.79%
Q1 2023
Q2Q % growth
0.10
-84.13%
0.060.0460.43%
Q4 2022
Q2Q % growth
0.43
-14.00%
0.190.24124.96%
Q3 2022
Q2Q % growth
0.14
-72.55%
0.38-0.24-62.77%
Q2 2022
Q2Q % growth
0.35
-23.91%
0.47-0.12-25.02%
Q1 2022
Q2Q % growth
0.63
43.18%
0.460.1738.44%
Q4 2021
Q2Q % growth
0.50
4.17%
0.54-0.04-8.04%
Q3 2021
Q2Q % growth
0.51
27.50%
0.380.1333.13%
Q2 2021
Q2Q % growth
0.46
9.52%
0.420.049.38%
Q1 2021
Q2Q % growth
0.44
18.92%
0.410.036.13%
Q4 2020
Q2Q % growth
0.48 0.310.1755.92%
Q3 2020
Q2Q % growth
0.40 0.320.0825.82%
Q2 2020
Q2Q % growth
0.42 0.320.1030.10%
Q1 2020
Q2Q % growth
0.37 0.350.025.07%
1CYTH.MI Yearly EPS VS Estimates1CYTH.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 2
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
3.087B
-4.16%
3.1B-13M-0.42%
Q2 2025
Q2Q % growth
3.092B
-5.39%
3.174B-82M-2.58%
Q1 2025
Q2Q % growth
3.182B
-3.28%
3.185B-3M-0.09%
Q4 2024
Q2Q % growth
3.329B
-5.35%
3.265B64M1.96%
Q3 2024
Q2Q % growth
3.221B
-11.54%
3.282B-61M-1.86%
Q2 2024
Q2Q % growth
3.268B
-10.73%
3.31B-42M-1.27%
Q1 2024
Q2Q % growth
3.29B
-11.99%
3.434B-144M-4.19%
Q4 2023
Q2Q % growth
3.517B
-7.45%
3.522B-5M-0.14%
Q3 2023
Q2Q % growth
3.641B
-17.06%
3.68B-39M-1.06%
Q2 2023
Q2Q % growth
3.661B
-20.62%
3.739B-78M-2.09%
Q1 2023
Q2Q % growth
3.738B
-20.06%
3.798B-60M-1.58%
Q4 2022
Q2Q % growth
3.8B
-21.60%
3.851B-51M-1.32%
Q3 2022
Q2Q % growth
4.39B
-10.17%
4.496B-106M-2.36%
Q2 2022
Q2Q % growth
4.612B
-6.34%
4.675B-63M-1.35%
Q1 2022
Q2Q % growth
4.676B
-7.02%
4.767B-91M-1.91%
Q4 2021
Q2Q % growth
4.847B
-5.42%
4.959B-112M-2.26%
Q3 2021
Q2Q % growth
4.887B
-5.42%
4.993B-106M-2.12%
Q2 2021
Q2Q % growth
4.924B
-5.16%
5.089B-165M-3.24%
Q1 2021
Q2Q % growth
5.029B
-3.81%
5.158B-129M-2.50%
Q4 2020
Q2Q % growth
5.125B 5.219B-94M-1.80%
Q3 2020
Q2Q % growth
5.167B 5.244B-77M-1.47%
Q2 2020
Q2Q % growth
5.192B 5.239B-47M-0.90%
Q1 2020
Q2Q % growth
5.228B 5.534B-306M-5.53%
1CYTH.MI Yearly Revenue VS Estimates1CYTH.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B 20B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS7% 31.59% 0.88% 33.59%
Revenue0.03% -0.9% 0.09% -0.17%